KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 13.71%.

  • Quest Diagnostics' EBIT Margin rose 4400.0% to 13.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.11%, marking a year-over-year increase of 9900.0%. This contributed to the annual value of 13.63% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Quest Diagnostics' EBIT Margin stood at 13.71%, which was up 4400.0% from 15.86% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' EBIT Margin ranged from a high of 24.26% in Q1 2021 and a low of 5.79% during Q4 2022
  • In the last 5 years, Quest Diagnostics' EBIT Margin had a median value of 14.88% in 2023 and averaged 15.63%.
  • Its EBIT Margin has fluctuated over the past 5 years, first surged by 146600bps in 2021, then tumbled by -137500bps in 2022.
  • Over the past 5 years, Quest Diagnostics' EBIT Margin (Quarter) stood at 19.53% in 2021, then tumbled by -70bps to 5.79% in 2022, then soared by 102bps to 11.67% in 2023, then grew by 18bps to 13.77% in 2024, then decreased by 0bps to 13.71% in 2025.
  • Its EBIT Margin was 13.71% in Q3 2025, compared to 15.86% in Q2 2025 and 13.05% in Q1 2025.